8 research outputs found
Double versus single intensive phototherapy with LEDs in treatment of neonatal hyperbilirubinemia
Insight into the metabolic mechanism of scoparone on biomarkers for inhibiting Yanghuang syndrome
Irradiance levels of phototherapy devices: a national study in Dutch neonatal intensive care units
Neurodevelopment after moderate hyperbilirubinemia at term
<p>BACKGROUND: The aim of this work was to investigate in a prospective study whether moderate hyperbilirubinemia in healthy term neonates is associated with an increase of minor neurological dysfunction (MND) and behavioral problems up to 18 mo.</p><p>METHODS: We enrolled 43 healthy term infants with a bilirubin level >= 220 mu mol/l (BILI group) at 72-96 h postnatally at the University Medical Center Groningen (UMCG), including eight referrals for hyperbilirubinemia. Seventy healthy term infants born at the UMCG with bilirubin level</p><p>RESULTS: Rates of MND in BILI and COMP groups were similar at all ages. However, bilirubin levels of >= 300 mu mol/l (n = 10) were associated with an increased risk of complex MND (odds ratio: 4.21; 95% confidence interval: 1.02-17.37). Neonatally, BILI infants were more often lethargic than COMP infants (odds ratio: 3.54; 95% confidence interval: 1.32-9.51); at 18 mo, they had higher hyperactivity scores (effect: 0.32; 95% confidence interval: 0.08-0.56).</p><p>CONCLUSION: Occurrence of complex MND at 18 mo in infants with moderate hyperbilirubinemia was not different from that in comparison infants, but bilirubin level >= 300 was associated with an increased risk of complex MND. This study also suggests that minor behavioral effects of moderate hyperbilirubinemia cannot be excluded.</p>